INR 172.0
(0.44%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | 119.21 Million | 50.14 Million | 47.28 Million | 27.27 Million | - |
Net Income | 63.53 Million | 18.14 Million | 4.17 Million | -29.14 Million | - |
Depreciation & Amortization | 39.06 Million | 35.86 Million | 32.3 Million | 30.82 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 6.32 Million | -27.18 Million | -9.34 Million | 4.51 Million | - |
Other non-cash items | 20.97 Million | 24.07 Million | 22.3 Million | 18.36 Million | - |
Investing Cash Flow | -69.64 Million | -45.03 Million | -76.98 Million | -35.78 Million | - |
Investments in PPE | -70.13 Million | -98.76 Million | -45.8 Million | -46.57 Million | - |
Acquisitions | - | - | - | - | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | -1000.00 | - | 1000.00 | - | - |
Financing Cash Flow | -41.36 Million | -5.02 Million | 28.64 Million | -7.45 Million | - |
Debt repayment | -68.16 Million | -22.27 Million | -52.98 Million | -14.52 Million | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 49.78 Million | - | - | - | - |
Other Financing Activities | -22.98 Million | - | - | -1000.00 | - |
Accounts receivables | -69.17 Million | - | - | - | - |
Accounts payables | - | - | - | - | - |
Inventory | 17.11 Million | -33.42 Million | -59.79 Million | 36.51 Million | - |
Other working capital | 58.38 Million | - | - | - | - |
Cash at beginning of period | 1.08 Million | 992 Thousand | 2.05 Million | 18.01 Million | - |
Cash at end of period | 9.28 Million | 1.08 Million | 992 Thousand | 2.05 Million | - |
Capital Expenditure | -70.13 Million | -98.76 Million | -45.8 Million | -46.57 Million | - |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | 8.2 Million | 89 Thousand | -1.05 Million | -15.96 Million | - |
Free Cash Flow | 49.08 Million | -48.61 Million | 1.47 Million | -19.29 Million | - |
Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY |
---|---|---|---|---|
Operating Cash Flow | - | - | - | - |
Net Income | 63.53 Million | 18.14 Million | 4.17 Million | -29.14 Million |
Depreciation & Amortization | 39.06 Million | 35.86 Million | 32.3 Million | 30.82 Million |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | 6.32 Million | -27.18 Million | -9.34 Million | 4.51 Million |
Other non-cash items | 20.97 Million | 24.07 Million | 22.3 Million | 18.36 Million |
Investing Cash Flow | -69.64 Million | -45.03 Million | -76.98 Million | -35.78 Million |
Investments in PPE | -70.13 Million | -98.76 Million | -45.8 Million | -46.57 Million |
Acquisitions | - | - | - | - |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | -1000.00 | - | 1000.00 | - |
Financing Cash Flow | -41.36 Million | -5.02 Million | 28.64 Million | -7.45 Million |
Debt repayment | -68.16 Million | -22.27 Million | -52.98 Million | -14.52 Million |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | 49.78 Million | - | - | - |
Other Financing Activities | - | - | - | -1000.00 |
Accounts receivables | - | - | - | - |
Accounts payables | - | - | - | - |
Inventory | 17.11 Million | -33.42 Million | -59.79 Million | 36.51 Million |
Other working capital | - | - | - | - |
Cash at beginning of period | 1.08 Million | 992 Thousand | 2.05 Million | 18.01 Million |
Cash at end of period | 9.28 Million | 1.08 Million | 992 Thousand | 2.05 Million |
Capital Expenditure | -70.13 Million | -98.76 Million | -45.8 Million | -46.57 Million |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | 8.2 Million | 89 Thousand | -1.05 Million | -15.96 Million |
Free Cash Flow | 49.08 Million | -48.61 Million | 1.47 Million | -19.29 Million |
DUNCANENG
ROSEMER
003041
WHBRADY
AMCOIND
MENEF